GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Cardia Bioplastics Ltd (ASX:CNN) » Definitions » Debt-to-EBITDA

Cardia Bioplastics (ASX:CNN) Debt-to-EBITDA : -0.30 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Cardia Bioplastics Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Cardia Bioplastics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.59 Mil. Cardia Bioplastics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.82 Mil. Cardia Bioplastics's annualized EBITDA for the quarter that ended in Dec. 2023 was A$-4.67 Mil. Cardia Bioplastics's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.30.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Cardia Bioplastics's Debt-to-EBITDA or its related term are showing as below:

ASX:CNN' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -2.53   Med: -1.01   Max: 4.09
Current: -0.27

During the past 13 years, the highest Debt-to-EBITDA Ratio of Cardia Bioplastics was 4.09. The lowest was -2.53. And the median was -1.01.

ASX:CNN's Debt-to-EBITDA is ranked worse than
100% of 327 companies
in the Packaging & Containers industry
Industry Median: 2.55 vs ASX:CNN: -0.27

Cardia Bioplastics Debt-to-EBITDA Historical Data

The historical data trend for Cardia Bioplastics's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardia Bioplastics Debt-to-EBITDA Chart

Cardia Bioplastics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.39 4.09 1.61 -1.55 -0.42

Cardia Bioplastics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.81 -0.82 -0.73 -0.32 -0.30

Competitive Comparison of Cardia Bioplastics's Debt-to-EBITDA

For the Packaging & Containers subindustry, Cardia Bioplastics's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cardia Bioplastics's Debt-to-EBITDA Distribution in the Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Cardia Bioplastics's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Cardia Bioplastics's Debt-to-EBITDA falls into.



Cardia Bioplastics Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Cardia Bioplastics's Debt-to-EBITDA for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.78 + 1.061) / -4.435
=-0.42

Cardia Bioplastics's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.585 + 0.815) / -4.666
=-0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.


Cardia Bioplastics  (ASX:CNN) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Cardia Bioplastics Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Cardia Bioplastics's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Cardia Bioplastics (ASX:CNN) Business Description

Traded in Other Exchanges
Address
247 Ferntree Gully Road, Unit 1, Mount Waverley, Melbourne, VIC, AUS, VIC 3149
SECOS Group Ltd is an Australian developer and manufacturer of sustainable packaging materials. . Business operating segment includes the manufacture and distribution of polyethylene films, renewable resource-based resins, and finished products. It supplies proprietary biodegradable resins, packaging products cast films to a customer base spread globally.SECOS Global Application Development Centre is in Australia. Product Development Centre and manufacturing plant for resins and finished products in China and resins plant in Malaysia. It also has manufacturing plants for cast films in Malaysia. It conducts sales via geographical regions that include Australia, Asia, America, Europe, and Africa. Asia generates maximum revenue for the company.

Cardia Bioplastics (ASX:CNN) Headlines

No Headlines